Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VCNX

Vaccinex (VCNX)

Vaccinex Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCNX
DateTimeSourceHeadlineSymbolCompany
12:49PMiHub NewswireFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
04/02/20248:30AMGlobeNewswire Inc.Vaccinex Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
03/27/20248:30AMGlobeNewswire Inc.Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VCNXVaccinex Inc
03/04/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
02/21/202410:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
02/21/20248:00AMGlobeNewswire Inc.Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyNASDAQ:VCNXVaccinex Inc
02/15/20248:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
02/15/20248:00AMGlobeNewswire Inc.Vaccinex, Inc. Announces Reverse Stock SplitNASDAQ:VCNXVaccinex Inc
02/13/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
02/13/20244:15PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
02/12/20244:22PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
02/09/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
02/09/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
02/09/20244:08PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VCNXVaccinex Inc
02/08/20248:20AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VCNXVaccinex Inc
02/07/20243:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
02/07/20248:00AMGlobeNewswire Inc.Vaccinex Announces Pricing of $3.7 Million PIPE FinancingNASDAQ:VCNXVaccinex Inc
01/22/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
01/19/20244:40PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
01/10/20245:16PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VCNXVaccinex Inc
01/08/20244:16PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VCNXVaccinex Inc
12/28/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
12/28/20234:15PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VCNXVaccinex Inc
12/12/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
12/04/20238:00AMGlobeNewswire Inc.Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing RuleNASDAQ:VCNXVaccinex Inc
11/13/20238:00AMGlobeNewswire Inc.Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
11/13/20237:46AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
11/03/20234:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
10/31/20239:00AMGlobeNewswire Inc.Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual MeetingNASDAQ:VCNXVaccinex Inc
10/26/20239:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
 Showing the most relevant articles for your search:NASDAQ:VCNX